-
Evaluation of mGlu4 Positive Allosteric Modulators in Models of Parkinson’s Disease
… score, bradykinesia, and ON time, without worsening of dyskinesia. Importantly, these studies also validated an …
-
Michael J. Fox Foundation Commits up to $5 Million for 2007-2008 Therapeutics Development Initiative
June 5, 2007
… to alleviate complications of PD treatment including dyskinesias. This program will have two grant cycles, the …
-
Michael J. Fox Foundation Launches Drug Discovery and Development Initiative
November 9, 2005
… and complications associated with treatment, including dyskinesias. Applications may focus on developing strategies …
-
Michael J. Fox Foundation Directs Drug Development and Discovery Effort to Stimulate Advances in Parkinson's
November 30, 2004
… including underlying motor symptoms of Parkinson’s disease, dyskinesias associated with treatment and neuroprotective …
-
Promising Parkinson's Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development
July 12, 2013
… decrease motor fluctuations and possibly reverse dyskinesia. To date, the Foundation has funded $325 million …
-
News in Context: Deep Brain Stimulation Offers Long-Term Benefits in Parkinson’s
April 23, 2021
… non-motor symptoms and complications, such as dyskinesia (involuntary movement), also improved long-term. …